Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell Point (India)'s Other Operating Expense for the
six
months ended in Mar. 2026 was ₹243 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹498 Mil.
Cell Point (India)'s quarterly Other Operating Expense
declined
from Mar. 2025 (₹263 Mil) to Sep. 2025 (₹255 Mil) and
declined
from Sep. 2025 (₹255 Mil) to Mar. 2026 (₹243 Mil).
Cell Point (India)'s annual Other Operating Expense
increased
from Mar. 2024 (₹103 Mil) to Mar. 2025 (₹251 Mil) and
increased
from Mar. 2025 (₹251 Mil) to Mar. 2026 (₹498 Mil).
Cell Point (India) Other Operating Expense Related Terms
Cell Point (India) Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹498 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹498 Mil mean?
Cell Point (India) (NSE:CELLPOINT) has a Other Operating Expense of ₹498 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Cell Point (India) and its competitors.
Is Cell Point (India)'s Other Operating Expense too high?
Cell Point (India)'s current Other Operating Expense is ₹498 Mil. Overall, Cell Point (India) has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Other Operating Expense compare to CASY and WSM?
Cell Point (India)'s Other Operating Expense of ₹498 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Retail - Cyclical company?
A good Other Operating Expense depends on the Retail - Cyclical industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cell Point (India) and its competitors. Cell Point (India)'s current Other Operating Expense is ₹498 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.91, compared to a current price of ₹15.25 — trading 56.3% below its estimated fair value. The current Other Operating Expense is ₹498 Mil. Cell Point (India)'s overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Other Operating Expense is ₹498 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹15.25 is trading 56.3% below its estimated GF Value™ of ₹34.91.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
Other Operating Expense: ₹498 Mil
GF Value™: ₹34.91 vs. price of ₹15.25 (56.3% below fair value)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
74GF Score
Get the complete analysis for NSE:CELLPOINT
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
